Professional FDA Medical Device Listing assistance for covered domestic and foreign device establishments — including product-code review, classification support, FURLS/DRLM submission, and ongoing listing maintenance.
Medical Device Listing is the electronic FDA filing used by covered device establishments to identify the devices they manufacture or process and the activities performed on those devices. Most establishments required to register under 21 CFR Part 807 must also list applicable devices through FDA's FURLS / Device Registration and Listing Module (DRLM). If a device requires 510(k), De Novo, PMA, or another applicable premarket authorization, that authorization must generally be obtained before the device is listed for U.S. marketing. Registration and listing do not mean FDA approval, clearance, certification, or endorsement.
FDA Medical Device Listing identifies devices associated with a registered device establishment and the activities performed on those devices. Most establishments required to register are also required to list applicable devices, but the obligation depends on the establishment type and activity. FDA Registration Assistance reviews the regulatory role first, then prepares the appropriate listing record.
We support product-code research, classification review, premarket-submission linkage when applicable, proprietary-name entry, electronic filing in FURLS/DRLM, and later listing updates. We also distinguish device listing from establishment registration and from FDA premarket authorization so each requirement is handled correctly.
A complete listing workflow focused on accurate product identification, correct regulatory linkage, clean electronic submission, and practical maintenance after filing.
We prepare the FDA listing record and submit it electronically through FURLS/DRLM, linking the device to the appropriate registered establishment and activity.
We research the applicable three-letter FDA product code and review device classification, intended use, and regulatory pathway before filing.
When a device requires 510(k), De Novo, PMA, HDE, or another applicable authorization, we verify the relevant FDA submission number is available and correctly linked before listing.
We support listing changes throughout the year and the annual October 1–December 31 review so records remain current as products, names, activities, or distribution status change.
Structured FDA listing assistance for companies that need accurate records, clear regulatory distinctions, and reliable annual maintenance.
A four-step process from device review through FDA submission and listing maintenance.
Provide the device name, intended use, description, establishment information, current labels, and any applicable premarket submission number.
We evaluate the likely FDA product code, device class, establishment activity, exemption status, and premarket-authorization linkage before preparing the listing.
We prepare and electronically submit the device listing through FDA's registration and listing system using the applicable establishment record.
We document the submission outcome and support later changes plus the annual October–December listing review so the record remains current.
Medical Device Listing is rooted in the FD&C Act and implemented through 21 CFR Part 807. FDA's electronic FURLS/DRLM process is the current filing method for registration and listing.
Section 510 establishes establishment registration and device listing duties for covered medical device operations. Listing identifies devices and regulated activities associated with registered establishments.
View Official FDA / eCFR SourcePart 807 defines which establishments register and list, the information that must be submitted, electronic filing requirements, annual review timing, and special requirements for foreign establishments.
View Official FDA / eCFR SourceFDA requires registration and listing information to be submitted electronically unless a waiver applies. FURLS/DRLM is used to create, maintain, and review device listing records.
View Official FDA / eCFR SourceA compliant listing record depends on accurate device identification, establishment activity, regulatory status, electronic submission, and ongoing maintenance.
Determine the establishment type and activity first because listing duties differ among manufacturers, contract manufacturers, specification developers, repackagers, relabelers, importers, and other entities.
Use intended use, design, the applicable classification regulation, and FDA databases to identify the relevant three-letter product code.
Determine whether the device is exempt or requires 510(k), De Novo, PMA, HDE, or another authorization; when authorization is required, obtain it before listing for U.S. marketing.
Enter current proprietary names and identify the activities the establishment performs on or to the device as required by FDA's listing process.
Create or update the listing in FURLS/DRLM using the correct establishment and owner/operator account information.
Review and update listing information each year between October 1 and December 31 at the same time annual establishment registration is reviewed.
Use FURLS/DRLM during the year to add, change, deactivate, or reactivate listings as products and activities change.
For covered foreign establishments, ensure registration and the required U.S. Agent designation are in place before devices are imported or offered for import into the United States.
Both are part of FDA's Part 807 framework, but they identify different things and applicability depends on establishment activity.
| Medical Device Listing | OptionEstablishment Registration | |
|---|---|---|
| What It Identifies | The device(s), proprietary names, product code, regulatory linkage, and activities performed | The establishment, owner/operator, location, establishment type, and related registration information |
| Who Files | Covered establishments required to list based on their device activity | Owners/operators of establishments required to register under 21 CFR Part 807 |
| FDA Fee | No separate FDA fee for the listing record itself | Annual FDA establishment registration user fee applies to most fee-paying establishments |
| Timing | Initial listing within the applicable 30-day period; annual review Oct 1–Dec 31; updates during the year as changes occur | Initial registration within the applicable period; annual registration Oct 1–Dec 31 |
| Premarket Authorization | If required, the device generally cannot be listed for U.S. marketing until the applicable submission is cleared, approved, or granted | Registration does not replace or provide premarket authorization |
| FDA Approval? | No — listing does not denote approval, clearance, certification, or authorization | No — registration does not denote approval, clearance, certification, or authorization |
Authorized company personnel can use FURLS/DRLM directly. A professional service adds regulatory research, filing support, and maintenance discipline.
| Self-Filing | OptionFDA Registration Assistance | |
|---|---|---|
| Professional Service Fee | $0; company handles research and filing internally | $249 per device |
| Product-Code Review | Company researches FDA classification databases and evaluates the correct code | Product-code and classification review included |
| Premarket Linkage | Company confirms whether an FDA authorization number is required before listing | Applicable authorization or exemption status reviewed before submission |
| FURLS / DRLM Filing | Company prepares and submits the listing itself | Listing record prepared and electronically submitted on the company's behalf |
| Ongoing Changes | Company monitors product, activity, name, and distribution changes | Support available for later listing updates and annual review |
| Documentation | Company maintains its own submission records | Submission records and confirmation information organized for the client |
A company can authorize others to assist with filing, but responsibility for accurate FDA information remains with the regulated firm.
| Informal / Internal Helper | OptionFDA Registration Assistance | |
|---|---|---|
| FDA Listing Fee | No separate FDA fee for the listing record | No separate FDA listing fee; $249 professional service fee per device |
| Regulatory Research | Depends on the helper's familiarity with Part 807 and device classification | Product-code, classification, and filing review included |
| Submission Process | Helper needs appropriate authorized access and DRLM knowledge | Structured electronic submission support through FURLS/DRLM |
| Accountability | The regulated establishment remains responsible for information submitted | The establishment remains legally responsible; our service provides documented professional handling |
| Maintenance | Depends on internal reminders and availability | Ongoing update and annual-review support available |
| Best Fit | Companies with trained in-house regulatory personnel | Companies that want external regulatory filing support and a consistent process |
Plain-English definitions of the terms most often encountered during FDA device registration and listing.
Common problems include mismatched device information, incorrect regulatory assumptions, incomplete establishment data, and records that are not updated when circumstances change.
A product code that does not match intended use or FDA classification can create inconsistent records and may require correction.
If the device requires clearance, approval, or another authorization, it generally cannot be listed for U.S. marketing until that authorization is obtained.
Using the wrong activity — manufacturer, contract manufacturer, repackager, relabeler, specification developer, or another role — can make the FDA record inaccurate.
Current proprietary or brand names should be maintained in the listing record. Incomplete names can make verification more difficult.
A listing tied to a registration that has not been properly renewed can create inactive or failed registration/listing status and disrupt the compliance record.
Covered foreign establishments must maintain the required U.S. Agent designation as part of registration. Unresolved agent confirmation or contact issues can interfere with registration.
New devices, discontinued devices, changed activities, or revised manufacturing associations should be reflected in DRLM as changes occur.
Registration and listing do not denote FDA approval, clearance, certification, or endorsement. Marketing claims suggesting otherwise can create separate compliance concerns.
Keep the full medical-device compliance workflow connected with related registration, U.S. Agent, labeling, quality-system, renewal, and import support.
Annual FDA establishment registration support for covered domestic and foreign medical device establishments.
Product-code, classification, and FURLS/DRLM listing support for covered device establishments.
Review device labeling and product documentation against applicable FDA labeling and regulatory requirements.
DUNS assistance for companies that need accurate business-identifier information for FDA device-registration workflows.
Annual U.S. Agent representation for covered foreign medical device establishments.
Professional verification document prepared from applicable FDA registration/listing records. Not issued or certified by FDA.
Support for FDA's Quality Management System Regulation (QMSR), effective February 2, 2026, and applicable quality-system requirements.
Annual FDA establishment registration renewal support during the October 1–December 31 renewal period.
Case-specific support for FDA medical-device detentions, import compliance issues, and Import Alert matters.
Prepare the FDA Laser Product Report / Radiation Safety Product Report, coordinate CDRH submission, and follow the accession number for applicable laser products.
Answers to common questions about who must list, how FDA listings work, fees, product codes, updates, and verification.
FDA Medical Device Listing is the electronic process by which covered registered establishments identify the devices they make or process and the activities performed on those devices. Most establishments required to register under 21 CFR Part 807 are also required to list applicable devices.
Most establishments that must register with FDA must also list their devices, but the requirement depends on the establishment's activity. Manufacturers, contract manufacturers, specification developers, repackagers, relabelers, and several other establishment types may have listing obligations; some entities, such as a wholesale distributor that does not manufacture, repackage, process, or relabel a device, are exempt.
U.S. manufacturers that manufacture devices for export only are a recognized establishment type and are required to register and list. For foreign establishments, U.S. registration/listing requirements are tied to devices imported or offered for import into the United States, so export-only situations should be evaluated based on the establishment's activity and destination market.
No. FDA states that registration and listing do not denote approval, clearance, authorization, certification, or endorsement of an establishment or its devices. If a device requires premarket authorization, that is a separate requirement.
An FDA medical device product code is generally a three-letter identifier for a generic device category. It connects the device to FDA's classification framework and helps identify the applicable regulation, class, and premarket requirements.
The product code is identified by comparing intended use, indications, design, technological characteristics, and applicable FDA classification regulation and databases. If a device has a cleared or approved premarket submission, the product code assigned to that authorization should be used.
FDA classifies devices into Class I, II, or III based on the regulatory controls needed to provide reasonable assurance of safety and effectiveness. Class, product code, exemptions, and premarket pathway are related but distinct parts of the analysis.
Often, yes. Being exempt from 510(k) does not automatically exempt an establishment from device listing. Whether listing is required depends on the establishment's activity and the specific device requirements.
FDA does not charge a separate government fee for creating a medical device listing record. Most fee-paying establishments must separately pay the annual establishment registration user fee. For FY 2026, FDA lists that fee as $11,423. Our Medical Device Listing professional service is $249 per device.
FDA says initial registration and/or listing information generally must be submitted within 30 days of beginning an activity or putting a device into commercial distribution. Listing information is reviewed each year between October 1 and December 31, and can be updated during the year as changes occur.
Yes. Covered foreign device establishments that manufacture, prepare, propagate, compound, or process devices imported into the United States must register and identify a U.S. Agent, and most such establishments must also list applicable devices and activities.
Device listing is an administrative FDA record associated with a registered establishment. A 510(k) is a premarket submission for devices that require clearance based on substantial equivalence. If a device requires 510(k) clearance, FDA says it can only be listed after the 510(k) is cleared.
Medical device listings are submitted electronically through FDA's Unified Registration and Listing System (FURLS), specifically the Device Registration and Listing Module (DRLM), unless FDA grants an electronic-submission waiver.
The listing process may require the product code, proprietary names, activities performed, and an applicable FDA premarket submission number when authorization is required. Exact fields depend on the device and establishment activity.
Yes. We can prepare and submit multiple device listings for one establishment or owner/operator, subject to the regulatory status and information available for each device. The $249 professional service fee applies per device.
Yes. Related services include establishment registration, U.S. Agent representation, DUNS assistance, labeling and product review, QMSR support, annual renewal, listing verification documentation, and import/detention support.
Our Medical Device Listing service is $249 per device. It includes product-code and classification review, listing-record preparation, applicable premarket-status review, FURLS/DRLM submission support, and confirmation documentation. FDA does not charge a separate fee for the listing record itself; an establishment registration fee may apply separately.
A company may authorize appropriate personnel or representatives to assist with registration and listing functions, but the regulated establishment remains responsible for the accuracy of its FDA information. Device-regulatory experience can reduce avoidable classification and filing mistakes.
A missing or inaccurate required listing can create a failed-to-list status and may make a device misbranded under applicable law. Depending on the facts, inaccurate registration/listing information can contribute to import delays, refusal, or other FDA compliance action. The consequence is case-specific rather than automatic.
Owners/operators can use FURLS/DRLM throughout the year to change, deactivate, or reactivate listings and update proprietary names and other listing information as changes occur. The annual October–December review is also used to confirm and update listing information.
Only products that meet the legal definition of a medical device are subject to device requirements. Many low-risk general-wellness products may fall outside device regulation depending on intended use and claims. Marketplace wording does not override FDA law; disease, diagnostic, treatment, or body-function claims can materially affect regulatory status.
A device may involve more than one product code when multiple regulated device functions or categories legitimately apply, but that determination should be based on FDA's classification framework and any applicable premarket authorization. It should not be assumed that every multi-function product needs multiple codes.
Not necessarily. Registration and listing duties are tied to the activity performed by each establishment. A contract manufacturer and a specification developer can each have their own registration/listing responsibilities for the same device, so one party's record does not automatically satisfy another party's obligations.
Yes. FDA makes releasable establishment registration and device listing information publicly searchable. FDA states that the public Registration & Listing database is updated weekly, usually every Monday.
An establishment registration number identifies a registered establishment, while a device listing number identifies a listing record associated with a medical device. One registered establishment can be associated with multiple device listings.
A facility move can require updates to establishment registration information and may affect linked device listings, depending on whether the change is an address correction or a move to a different physical establishment. The change should be reviewed in FURLS/DRLM so associations remain accurate.
If the product is a regulated medical device and the responsible establishment has registration/listing duties, marketplace sales do not eliminate those FDA requirements. Amazon, Walmart, Shopify, or another platform is a sales channel; FDA requirements depend on the product and regulated activities, not the platform alone.
A buyer or distributor can search FDA's public Establishment Registration & Device Listing database by company, device, product code, registration/FEI number, and other fields. FDA says the database is updated weekly, usually every Monday. A private verification certificate can summarize public records, but it is not issued or certified by FDA.
FDA requires registration information to be submitted and listing information to be reviewed each year between October 1 and December 31. If annual establishment registration is not completed, the establishment can lose active registration status and linked listings may no longer appear current. FDA does not describe a separate FDA-issued listing-certificate renewal.
Software that meets the statutory definition of a medical device may be subject to registration, listing, and applicable premarket requirements. Whether a software function is regulated depends on intended use and whether it falls within statutory exclusions, FDA enforcement policies, or regulated device-software categories.
Send us your device and establishment details. We will review the regulatory pathway, confirm what listing information is needed, and prepare the FDA submission.
We've received your message and will get back to you within 24 hours. If you need immediate assistance, please call us directly.